No, patients should not commence GLP-1 receptor agonists solely for potential cognitive effects without medical consultation
He said half of his patients who had to stop the drug gained the weight back
partner to bring ecnoglutide to American patients, and is pursuing partnerships in Latin America and the Middle East
[2] In fact, I would argue that due to our current farming practices and the Standard American Diet (S.A.D.), micronutrient depletions are a factor for most people
GLP-1 medications commonly cause GI effects initially, while phentermine may increase stimulant-related symptoms
Despite these excellent findings, researchers should note the potential for minor and transient side effects generally associated peptide administration: Injection site pain Dizziness Headache Fatigue Nausea Adverse effects may be more common with the use of low-quality peptides from unverified sources